Ignite Creation Date:
2025-12-24 @ 5:10 PM
Ignite Modification Date:
2025-12-25 @ 2:47 PM
Study NCT ID:
NCT03060850
Status:
UNKNOWN
Last Update Posted:
2019-02-01
First Post:
2017-02-10
Is NOT Gene Therapy:
False
Has Adverse Events:
False
Brief Title:
A Phase I Study of AC0010 in Patients With CLL/ SLL, MCL, DLBCL and Other NHL
Sponsor:
Hangzhou ACEA Pharmaceutical Research Co., Ltd.
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2017-03-17
Start Date Type:
ACTUAL
Primary Completion Date:
2019-12-14
Primary Completion Date Type:
ESTIMATED
Completion Date:
2020-12-14
Completion Date Type:
ESTIMATED
First Submit Date:
2017-02-10
First Submit QC Date:
None
Study First Post Date:
2017-02-23
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2019-01-31
Last Update Post Date:
2019-02-01
Last Update Post Date Type:
ACTUAL